CORDIS · 101059870 · HORIZON
PharmGenHUB Pharmacogenomics Hub in a strengthened IMGGE
Coordinator: INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO (RS)
Personalized medicine uses pharmacogenomics (PGX) to individualize therapy upon patients’ unique DNA profiles. With ~200,000 deaths/year in Europe due to adverse drug reactions, it has become an imperative to improve treatment. In Western Balkans (WB), individualization of therapy is done sporadically. IMGGE (Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Serbia) is a pioneer in the PGX in WB. PharmGenHUB will strengthen IMGGE’s PGX R&I potential by exchanging knowledge between IMGGE and EU partnering institutions: University of Patras, Greece (UPAT), Univers…
About Horizon Europe (2021–2027)
Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.
EU contribution: €1.3M awarded to the consortium. The project runs over approximately 3 years from 2022-07-01 to 2025-06-30.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu → Grant DOI ↗More from RS
see all →- CROSS-REIS — CROSS-disciplinary network for research excellence in Regenerative Economy Innovation eco-Systems101136834 · HORIZON · €4.4M
- EINSTEIN — EXCELLENCE INITIATIVE FOR NUTRIFOOD-BASED THERANOSTICS FOR HEALTHY EUROPEAN SOCIETY101136377 · HORIZON · €3.9M
- SENSEIVER — Low-cost and energy-efficient LTCC sensor/IR-UWB transceiver solutions for sustainable healthy environment289481 · FP7 · €3.0M
- INNOSENSE — Reinforcement of BioSense Center – ICT for Sustainability and Eco-Innovation316191 · FP7 · €2.6M
- HEROMAT — PROTECTION OF CULTURAL HERITAGE OBJECTS WITH MULTIFUNCTIONAL ADVANCED MATERIALS282992 · FP7 · €2.6M
- HIP-2D-QM — HIDDEN PHASES IN 2D-QUANTUM MATERIALS101185375 · HORIZON · €2.5M
Other HORIZON projects
see all →- EUROfusion — Implementation of activities described in the Roadmap to Fusion during Horizon Europe through a joint programme of the members of the EUROfusion consortium101052200 · DE · €549.4M
- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · ES · €206.9M
- PARC — Partnership for the Assessment of Risks from Chemicals101057014 · FR · €200.0M
- EIT RM BP23-25 — EIT RawMatrials Business Plan 2023-2025101113034 · DE · €155.5M
- SGA1-HE — COST: Europe's most empowering research programme Strengthening science and innovation through research networking101052416 · BE · €153.0M
- EIT HEI — EIT Higher Education Initiative - Scaling Europe’s Innovation Ecosystems101270329 · DE · €130.0M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-CSA funding scheme.
- What is the EU contribution?
- The European Commission contributes €1.3M toward a total project budget of €1.3M.
- Which EU programme funds it?
- The project is funded under Horizon Europe (2021–2027), call HORIZON-WIDERA-2021-ACCESS-02.
- Who coordinates the project?
- The project is coordinated by INSTITUT ZA MOLEKULARNU GENETIKU I GENETICKO INZENJERSTVO (RS).
- What is the project timeline?
- The project runs from 2022-07-01 to 2025-06-30 — approximately 3 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101059870.